Renal Cancer - Results from #460

The Prevalence and Radiologic Features of Renal Cancers Associated with FLCN, BAP1, SDH, and MET Germline Mutations. March 12, 2024

Dose-response of localized renal cell carcinoma after stereotactic body radiation therapy: A meta-analysis. March 12, 2024

Detection of Testicular Metastasis from Renal Cell Carcinoma on PSMA-PET Scan. March 12, 2024

Impact of chronic kidney disease stages on surgical and functional outcomes in robot-assisted partial nephrectomy for localized renal tumors. March 11, 2024

Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma. March 11, 2024

Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma. March 8, 2024

The Survival Outcomes of the Metastatic Nonclear Cell Renal Cell Carcinoma in the Immunotherapy Era: Princess Margaret Cancer Centre Experience. March 8, 2024

The Impact of Nursing Interventions on the Treatment Outcomes of Renal Cell Carcinoma with Postoperative Interleukin-2 and Recombinant Human Interferon March 7, 2024

Linear Muscle Segmentation for Metastatic Renal Cell Carcinoma: Changes in Clinic-Friendly Estimation Predict Survival Following Cytoreductive Nephrectomy. March 7, 2024

The prognostic role of histomorphological subtyping in nonmetastatic papillary renal cell carcinoma after curative surgery: is subtype really irrelevant? A propensity score matching analysis of a multi-institutional real life data. March 7, 2024

The impact of metastasectomy on survival of patients with synchronous metastatic renal cell cancer in Finland: A nationwide study. March 6, 2024

Advanced Renal Cell Carcinoma With Inferior Vena Cava Thrombus Treated With a Combination of Preoperative Lenvatinib and Pembrolizumab. March 6, 2024

The incidence, pathogenesis, and management of non-clear cell renal cell carcinoma. March 5, 2024

Partial nephrectomy for renal tumors: recommendations of the Italian Society of Urology RCC working group. March 5, 2024

Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial. March 4, 2024

Nurse-led renal cell carcinoma clinic: a single center review. March 4, 2024

Neighborhood social vulnerability and disparities in time to kidney cancer surgical treatment and survival in Arizona. March 1, 2024

Cytokine Signaling in Pediatric Kidney Tumor Cell Lines WT-CLS1, WT-3ab and G-401. March 1, 2024

Survival pattern of metastatic renal cell carcinoma patients according to WHO/ISUP grade: a long-term multi-institutional study. February 29, 2024

A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. February 29, 2024

Page 24 of 456